Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah McGaugh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diabetes Technology & Therapeutics|February 19, 2020
Advances in Exercise, Physical Activity, and DiabetesDessi P Zaharieva, Sarah McGaugh, Elizabeth A Davis, et al.
The Lancet. Diabetes & Endocrinology|May 24, 2020
Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trialRonnie Aronson, Aihua Li, Ruth E Brown, et al.
Diabetes Care|February 24, 2019
Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionDessi P Zaharieva, Sarah McGaugh, Rubin Pooni, et al.
Frontiers in Pharmacology|February 17, 2018
HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney DiseaseAngela S Brijmohan, Sri N Batchu, Syamantak Majumder, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diabetes Technology & Therapeutics|February 19, 2020
Advances in Exercise, Physical Activity, and DiabetesDessi P Zaharieva, Sarah McGaugh, Elizabeth A Davis, et al.
The Lancet. Diabetes & Endocrinology|May 24, 2020
Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trialRonnie Aronson, Aihua Li, Ruth E Brown, et al.
Diabetes Care|February 24, 2019
Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionDessi P Zaharieva, Sarah McGaugh, Rubin Pooni, et al.
Frontiers in Pharmacology|February 17, 2018
HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney DiseaseAngela S Brijmohan, Sri N Batchu, Syamantak Majumder, et al.
Pageof 1